Two vignettes—Ativan and Teva—offer a closer look at the routines that hold polypharmacy in place.
The description of these two cases reveals so much. All the general talk in the media about oversubscribing comes to a quick conclusion- continue.
Readers will come away determined to think critically. But will that sustain itself in a real situation? We think not.
The description of these two cases reveals so much. All the general talk in the media about oversubscribing comes to a quick conclusion- continue.
Readers will come away determined to think critically. But will that sustain itself in a real situation? We think not.